Upgrade to SI Premium - Free Trial

Kura Oncology (KURA)

10.45 -0.09 (0.85%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Leerink Assumes Kura Oncology (KURA) at Outperform July 21, 2026 4:49 PM - StreetInsider Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026 July 14, 2026 7:02 AM - Globe NewsWire Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 3, 2026 7:30 AM - Globe NewsWire Form 4 Kura Oncology, Inc. For: Jun 18 Filed by: Leoni Mollie June 22, 2026 6:00 PM - SEC Filing Form 144 Kura Oncology, Inc. Filed by: Leoni Mollie June 18, 2026 4:23 PM - SEC Filing Kura Oncology (KURA) Reiterated at Market Outperform by Citizens After Data Presentation June 15, 2026 5:13 AM - StreetInsider Kura Oncology reports positive long-term cancer drug trial data June 11, 2026 8:03 AM - StreetInsider Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML June 11, 2026 8:02 AM - Globe NewsWire Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 5, 2026 7:30 AM - Globe NewsWire Form 4 Kura Oncology, Inc. For: Jun 04 Filed by: Hasnain Faheem June 4, 2026 6:30 PM - SEC Filing Form 4 Kura Oncology, Inc. For: Jun 04 Filed by: Parks Diane L. June 4, 2026 6:30 PM - SEC Filing Form 4 Kura Oncology, Inc. For: Jun 04 Filed by: VASCONCELLES MICHAEL June 4, 2026 6:30 PM - SEC Filing Form 4 Kura Oncology, Inc. For: Jun 04 Filed by: Collins Helen Louise June 4, 2026 6:30 PM - SEC Filing Form 4 Kura Oncology, Inc. For: Jun 04 Filed by: Szela Mary T June 4, 2026 6:30 PM - SEC Filing Form 4 Kura Oncology, Inc. For: Jun 04 Filed by: Malley Thomas June 4, 2026 6:30 PM - SEC Filing Form 4 Kura Oncology, Inc. For: Jun 04 Filed by: SCHAFER CAROL June 4, 2026 6:30 PM - SEC Filing Form S-8 Kura Oncology, Inc. June 4, 2026 5:25 PM - SEC Filing Form 8-K Kura Oncology, Inc. For: Jun 04 June 4, 2026 4:05 PM - SEC Filing Kura Oncology (KURA) Reiterated at Overweight by Cantor Fitzgerald June 4, 2026 7:07 AM - StreetInsider Kura Oncology (KURA) Reiterated at Market Outperform by Citizens June 4, 2026 5:25 AM - StreetInsider Kura Oncology reports clinical trial data for cancer drug darlifarnib June 3, 2026 6:55 AM - StreetInsider Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy June 3, 2026 6:53 AM - Globe NewsWire Kura Oncology publishes ziftomenib combination study in Blood journal June 2, 2026 8:33 AM - StreetInsider Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML June 2, 2026 8:32 AM - Globe NewsWire Kura Oncology (KURA) Reiterated at Market Outperform by Citizens on FIT-001 Data Preview May 28, 2026 5:21 AM - StreetInsider Form DEFA14A Kura Oncology, Inc. May 26, 2026 4:42 PM - SEC Filing KURA reports tumor shrinkage in 77% of patients in drug combination trial May 26, 2026 6:02 AM - StreetInsider Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors May 26, 2026 6:02 AM - Globe NewsWire Form 4 Kura Oncology, Inc. For: May 21 Filed by: Powl Brian T. May 22, 2026 4:06 PM - SEC Filing Form 144 Kura Oncology, Inc. Filed by: Powl Brian T. May 21, 2026 4:32 PM - SEC Filing Form 4 Kura Oncology, Inc. For: May 19 Filed by: Powl Brian T. May 20, 2026 4:06 PM - SEC Filing Form 4 Kura Oncology, Inc. For: May 18 Filed by: Bair Teresa Brophy May 20, 2026 4:06 PM - SEC Filing Form 4 Kura Oncology, Inc. For: May 19 Filed by: FORD KATHLEEN May 20, 2026 4:05 PM - SEC Filing Form 144 Kura Oncology, Inc. Filed by: FORD KATHLEEN May 19, 2026 4:39 PM - SEC Filing Form 144 Kura Oncology, Inc. Filed by: Powl Brian T. May 19, 2026 4:38 PM - SEC Filing Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit May 19, 2026 4:02 PM - Globe NewsWire Form 144 Kura Oncology, Inc. Filed by: Bair Teresa Brophy May 18, 2026 4:32 PM - SEC Filing Form SCHEDULE 13G/A Kura Oncology, Inc. Filed by: ARMISTICE CAPITAL, LLC May 15, 2026 11:26 AM - SEC Filing Kura Oncology (KURA) Reiterated at Market Outperform by Citizens After Q1 Results May 13, 2026 5:48 AM - StreetInsider Form 10-Q Kura Oncology, Inc. For: Mar 31 May 12, 2026 4:16 PM - SEC Filing Form 8-K Kura Oncology, Inc. For: May 12 May 12, 2026 4:11 PM - SEC Filing Kura Oncology (KURA) Reports In-Line Q1 EPS May 12, 2026 4:02 PM - StreetInsider Kura Oncology Reports First Quarter 2026 Financial Results May 12, 2026 4:02 PM - Globe NewsWire Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress May 12, 2026 9:41 AM - StreetInsider Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress May 12, 2026 9:40 AM - Globe NewsWire Kura Oncology to Participate in Bank of America Securities Healthcare Conference May 6, 2026 7:30 AM - Globe NewsWire Kura Oncology to Report First Quarter 2026 Financial Results May 5, 2026 7:30 AM - Globe NewsWire Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 4, 2026 7:30 AM - Globe NewsWire Form SCHEDULE 13G Kura Oncology, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 30, 2026 11:01 AM - SEC Filing Full Article List